Literature DB >> 16228229

A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency.

Natalia Martinez-Pomar1, Ivan Munoz-Saa, Damian Heine-Suner, Ana Martin, Asma Smahi, Nuria Matamoros.   

Abstract

Incontinentia pigmenti is an X-linked genodermatosis, lethal in males. Affected females survive because of X-chromosome dizygosity and negative selection of cells carrying the mutant X-chromosome, and for this reason the skewed X inactivation pattern is often used to confirm the diagnosis. The most frequent mutation is a deletion of part of the NEMO gene (NEMODelta4-10), although other mutations have been reported. Mutations of NEMO which do not abolish NF-kappaB activity totally permit male survival, causing an allelic variant of IP called hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID). We present a non-classical IP female patient who also suffered transient immunodeficiency because of a late and progressive selection against peripheral blood cells carrying an active mutated X-chromosome. This finding suggests that in the absence of known mutation the X-inactivation studies used in genetic counselling can induce mistakes with some female patients. At the age of 3 years and 6 months, all immunodeficiency signs disappeared, and the X-chromosome inactivation pattern was completely skewed. The low T cell proliferation and CD40L expression corroborate the important role of NEMO/ NF-kappaB pathway in T cell homeostasis. The decreased NEMO protein amount and the impaired IkBalpha degradation suggest that this new mutation, NM_003639: c.1049dupA, causes RNA or protein instability. To our knowledge, this is the first time that selection against the mutated X-chromosome in X-linked disease has been documented in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16228229     DOI: 10.1007/s00439-005-0068-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.

Authors:  D M Rothwarf; E Zandi; G Natoli; M Karin
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

2.  Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID).

Authors:  K Kosaki; N Shimasaki; H Fukushima; M Hara; T Ogata; N Matsuo
Journal:  Am J Hum Genet       Date:  2001-09       Impact factor: 11.025

3.  Mature T cells depend on signaling through the IKK complex.

Authors:  Marc Schmidt-Supprian; Gilles Courtois; Jane Tian; Anthony J Coyle; Alain Israël; Klaus Rajewsky; Manolis Pasparakis
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

4.  Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.

Authors:  Tim Niehues; Janine Reichenbach; Jennifer Neubert; Sonja Gudowius; Anne Puel; Gerd Horneff; Elke Lainka; Uta Dirksen; Horst Schroten; Rainer Döffinger; Jean Laurent Casanova; Volker Wahn
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

5.  Clinical study of 40 cases of incontinentia pigmenti.

Authors:  Smaïl Hadj-Rabia; David Froidevaux; Nathalie Bodak; Dominique Hamel-Teillac; Asma Smahi; Yasmina Touil; Sylvie Fraitag; Yves de Prost; Christine Bodemer
Journal:  Arch Dermatol       Date:  2003-09

6.  X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.

Authors:  Ryuta Nishikomori; Hiroshi Akutagawa; Kyoko Maruyama; Mami Nakata-Hizume; Katsuyuki Ohmori; Kazunori Mizuno; Akihiro Yachie; Takahiro Yasumi; Takashi Kusunoki; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

7.  Fragile-X syndrome and skewed X-chromosome inactivation within a family: a female member with complete inactivation of the functional X chromosome.

Authors:  D Heine-Suñer; L Torres-Juan; M Morlà; X Busquets; F Barceló; G Picó; L Bonilla; N Govea; M Bernués; J Rosell
Journal:  Am J Med Genet A       Date:  2003-10-01       Impact factor: 2.802

8.  A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.

Authors:  Gilles Courtois; Asma Smahi; Janine Reichenbach; Rainer Döffinger; Caterina Cancrini; Marion Bonnet; Anne Puel; Christine Chable-Bessia; Shoji Yamaoka; Jacqueline Feinberg; Sophie Dupuis-Girod; Christine Bodemer; Susanna Livadiotti; Francesco Novelli; Paolo Rossi; Alain Fischer; Alain Israël; Arnold Munnich; Françoise Le Deist; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

9.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.

Authors:  A Smahi; G Courtois; P Vabres; S Yamaoka; S Heuertz; A Munnich; A Israël; N S Heiss; S M Klauck; P Kioschis; S Wiemann; A Poustka; T Esposito; T Bardaro; F Gianfrancesco; A Ciccodicola; M D'Urso; H Woffendin; T Jakins; D Donnai; H Stewart; S J Kenwrick; S Aradhya; T Yamagata; M Levy; R A Lewis; D L Nelson
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

10.  The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.

Authors:  Riny Janssen; Annelies van Wengen; Marieke A Hoeve; Monique ten Dam; Miriam van der Burg; Jacques van Dongen; Esther van de Vosse; Maarten van Tol; Robbert Bredius; Tom H Ottenhoff; Corry Weemaes; Jaap T van Dissel; Arjan Lankester
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

View more
  16 in total

1.  Clinical features of incontinentia pigmenti with emphasis on oral and dental abnormalities.

Authors:  Snezana Minić; Gerd E K Novotny; Dusan Trpinac; Miljana Obradović
Journal:  Clin Oral Investig       Date:  2006-08-08       Impact factor: 3.573

2.  Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.

Authors:  Hidenori Ohnishi; Yuka Kishimoto; Tomohide Taguchi; Norio Kawamoto; Mina Nakama; Tomoki Kawai; Manabu Nakayama; Osamu Ohara; Kenji Orii; Toshiyuki Fukao
Journal:  J Clin Immunol       Date:  2017-07-12       Impact factor: 8.317

3.  NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.

Authors:  Magali Audry; Michael Ciancanelli; Kun Yang; Aurelie Cobat; Huey-Hsuan Chang; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Tim Niehues; Janine Reichenbach; Xiao-Xia Li; Alain Israel; Laurent Abel; Jean-Laurent Casanova; Shen-Ying Zhang; Emmanuelle Jouanguy; Anne Puel
Journal:  J Allergy Clin Immunol       Date:  2011-07-01       Impact factor: 10.793

Review 4.  Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.

Authors:  Capucine Picard; Jean-Laurent Casanova; Anne Puel
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case-control study.

Authors:  Morten Frost; Michaela Tencerova; Christina M Andreasen; Thomas L Andersen; Charlotte Ejersted; Dea Svaneby; Weimin Qui; Moustapha Kassem; Allahdad Zarei; William H McAlister; Deborah J Veis; Michael P Whyte; Anja L Frederiksen
Journal:  Bone       Date:  2019-01-16       Impact factor: 4.398

Review 6.  Dental and oral anomalies in incontinentia pigmenti: a systematic review.

Authors:  Snežana Minić; Dušan Trpinac; Heinz Gabriel; Martin Gencik; Miljana Obradović
Journal:  Clin Oral Investig       Date:  2012-03-28       Impact factor: 3.573

7.  Importance of long-time simulations for rare event sampling in zinc finger proteins.

Authors:  Ryan Godwin; William Gmeiner; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2015-04-09

8.  The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.

Authors:  Min-Jung Song; Jong-Hee Chae; Eun-Ae Park; Chang-Seok Ki
Journal:  J Korean Med Sci       Date:  2010-09-20       Impact factor: 2.153

9.  Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

Authors:  Eric P Hanson; Linda Monaco-Shawver; Laura A Solt; Lisa A Madge; Pinaki P Banerjee; Michael J May; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

10.  T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.

Authors:  Stephanie Heller; Uwe Kölsch; Thomas Magg; Renate Krüger; Andrea Scheuern; Holm Schneider; Anna Eichinger; Volker Wahn; Nadine Unterwalder; Myriam Lorenz; Klaus Schwarz; Christian Meisel; Ansgar Schulz; Fabian Hauck; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2020-01-21       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.